open access

Vol 10, No 2 (2007)
Clinical nuclear medicine
Published online: 2007-05-23
Submitted: 2012-01-23
Get Citation

Correlations between biochemical testing, pathology findings and preoperative sestamibi scans: a retrospective study of the minimally invasive radioguided parathyroidectomy (MIRP) approach

Stanislaw Peter Stawicki, Maher El Chaar, Daniel R. Baillie, Nikhil P. Jaik, Fernando P. Estrada
Nucl. Med. Rev 2007;10(2):82-86.

open access

Vol 10, No 2 (2007)
Clinical nuclear medicine
Published online: 2007-05-23
Submitted: 2012-01-23

Abstract

BACKGROUND: Sestamibi imaging is the most widely used preoperative localization study for patients with hyperparathyroidism. Previous reports examine the relationship between the weight and volume of excised parathyroid glands and preoperative serum calcium and parathyroid hormone (PTH) levels. The aim of this study was to examine whether these variables correlate with the results of preoperative Sestamibi scans.
MATERIAL AND METHODS: A retrospective review of 150 consecutive patients who underwent preoperative sestamibi imaging for primary hyperparathyroidism between 1998 and 2007 was performed. Variables studied included patient demographics, diagnostic test (sestamibi) results, operative/pathology findings and surgical outcome (normocalcaemia vs. persistent hypercalcaemia). Sestamibi scans were designated as either "negative" (NSS) or "positive" (PSS), where PSS correctly localized abnormal gland(s) enabling a focused neck exploration. The results of sestamibi imaging were correlated with calcium/PTH levels, weight/volume of excised glands and patient outcomes and demographics.
RESULTS: Total excised gland weight/volume and preoperative serum calcium levels were significantly higher with PSS (all, p < 0.04). Higher preoperative serum calcium levels and greater total gland weight/volume were significantly associated with successful operative outcome (presence of postoperative normocalcaemia; all, p < 0.01). Factors associated with operative failure included multi-gland disease (p < 0.01) and NSS (p < < 0.01). Higher diagnostic PTH levels (> 150 pg/mL) were associated with greater excised gland mass (p < 0.05) and volume (p < 0.05). Male gender was associated with higher preoperative serum calcium levels (p < 0.02). Of interest, patients with single-gland disease had significantly higher preoperative PTH levels than patients with multi-gland disease (155 vs. 109 pg/mL, p < 0.05).
CONCLUSION: Positive sestamibi scans are associated with heavier/larger parathyroid glands and higher preoperative serum calcium levels. Male gender was associated with higher preoperative serum calcium levels, while single-gland disease was associated with higher preoperative PTH levels. In addition, successful surgical outcome was associated with higher preoperative serum calcium levels and with greater excised parathyroid gland mass/volume. Surgical failure was associated with multi-gland disease and negative sestamibi.

Abstract

BACKGROUND: Sestamibi imaging is the most widely used preoperative localization study for patients with hyperparathyroidism. Previous reports examine the relationship between the weight and volume of excised parathyroid glands and preoperative serum calcium and parathyroid hormone (PTH) levels. The aim of this study was to examine whether these variables correlate with the results of preoperative Sestamibi scans.
MATERIAL AND METHODS: A retrospective review of 150 consecutive patients who underwent preoperative sestamibi imaging for primary hyperparathyroidism between 1998 and 2007 was performed. Variables studied included patient demographics, diagnostic test (sestamibi) results, operative/pathology findings and surgical outcome (normocalcaemia vs. persistent hypercalcaemia). Sestamibi scans were designated as either "negative" (NSS) or "positive" (PSS), where PSS correctly localized abnormal gland(s) enabling a focused neck exploration. The results of sestamibi imaging were correlated with calcium/PTH levels, weight/volume of excised glands and patient outcomes and demographics.
RESULTS: Total excised gland weight/volume and preoperative serum calcium levels were significantly higher with PSS (all, p < 0.04). Higher preoperative serum calcium levels and greater total gland weight/volume were significantly associated with successful operative outcome (presence of postoperative normocalcaemia; all, p < 0.01). Factors associated with operative failure included multi-gland disease (p < 0.01) and NSS (p < < 0.01). Higher diagnostic PTH levels (> 150 pg/mL) were associated with greater excised gland mass (p < 0.05) and volume (p < 0.05). Male gender was associated with higher preoperative serum calcium levels (p < 0.02). Of interest, patients with single-gland disease had significantly higher preoperative PTH levels than patients with multi-gland disease (155 vs. 109 pg/mL, p < 0.05).
CONCLUSION: Positive sestamibi scans are associated with heavier/larger parathyroid glands and higher preoperative serum calcium levels. Male gender was associated with higher preoperative serum calcium levels, while single-gland disease was associated with higher preoperative PTH levels. In addition, successful surgical outcome was associated with higher preoperative serum calcium levels and with greater excised parathyroid gland mass/volume. Surgical failure was associated with multi-gland disease and negative sestamibi.
Get Citation

Keywords

parathyroid hormone; PTH; sestamibi imaging; minimally invasive radioguided parathyroidectomy; MIRP

About this article
Title

Correlations between biochemical testing, pathology findings and preoperative sestamibi scans: a retrospective study of the minimally invasive radioguided parathyroidectomy (MIRP) approach

Journal

Nuclear Medicine Review

Issue

Vol 10, No 2 (2007)

Pages

82-86

Published online

2007-05-23

Bibliographic record

Nucl. Med. Rev 2007;10(2):82-86.

Keywords

parathyroid hormone
PTH
sestamibi imaging
minimally invasive radioguided parathyroidectomy
MIRP

Authors

Stanislaw Peter Stawicki
Maher El Chaar
Daniel R. Baillie
Nikhil P. Jaik
Fernando P. Estrada

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl